| Drug Name: | beta-Naphthoflavone (6051-87-2) |
|---|---|
| PubChem ID: | 2361 |
| SMILES: | C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC4=CC=CC=C43 |
| InchiKey: | OUGIDAPQYNCXRA-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 272.303 |
| LogP | : | 4.6132 |
| Ring Count | : | 4 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 30.21 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Adenoma | MetaADEDB |
| Congenital Abnormalities | MetaADEDB |
| Liver Neoplasms | MetaADEDB |
| Liver Neoplasms Experimental | MetaADEDB |
| Precancerous Conditions | MetaADEDB |
| Prenatal Injuries | MetaADEDB |